mTORC1 to AMPK switching underlies ß-cell metabolic plasticity during maturation and diabetes. (2019)
Attributed to:
Targeting GLP-1 receptor trafficking to improve therapies for type 2 diabetes
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1172/jci127021
PubMed Identifier: 31265435
Publication URI: http://europepmc.org/abstract/MED/31265435
Type: Journal Article/Review
Volume: 129
Parent Publication: The Journal of clinical investigation
Issue: 10
ISSN: 0021-9738